top of page

192nd Bi-monthly Scientific Meeting - 16th May 2013

May 16, 2013
1 min read
Presentations

Anticholestatic effects of bezafibrate in patients with primary biliary cirhrosis treated with UDCA

Dr Wing-I Cheung (Our Lady of Maryknoll Hospital, Hong Kong)

Related Posts

See All

© 2026 by The Hong Kong Association for the Study of Liver Diseases

bottom of page